Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immunocore Ltd.. (5/12/17). "Press Release: Abbas Hussain Joins the Board of Immunocore as Non-executive Director. Ian T. Clark Also Appointed as Special Adviser to the Board". Oxford & Conshohocken, PA. 2017-05-12
Microsaic Systems plc. (5/11/17). "Press Release: Microsaic Enhances Capabilities of Its 4000 MiD Miniaturised Mass Spectrometer for Bioprocessing Applications". 2017-05-11
Scancell Holdings plc. (5/11/17). "Press Release: Placing Raises £5.0 Million, Issue of Equity and PDMR Shareholding [Not for relase in, into or from any jurisdiction where this would constitute a violation of relavant laws or regulations]". 2017-05-11
Macrophage Pharma Ltd.. (5/11/17). "Press Release: Macrophage Pharma Appoints Development Director. Dr Joanne Bedwell-Garner Joins Management Team". 2017-05-11
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. 2017-05-10
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Reports First Quarter 2017 Financial Results". Philadeliphia, PA & Oxford. 2017-05-10
Exscientia Ltd.. (5/9/17). "Press Release: Exscientia Announces EUR 250 Million Collaboration for Multiple-product Development and Licence Option Agreement with Sanofi". 2017-05-09
Microbiotica Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director". 2017-05-09
PolyPico Technologies Ltd.. (5/8/17). "Press Release: Precision Gets a Whole New Meaning with the Launch of the PicoPRECISE". Galway. 2017-05-08
Consilium Strategic Communications Ltd.. (5/8/17). "Press Release: Consilium Strategic Communications Strengthens Senior International Healthcare Team with the Appointment of Philippa Gardner and Suki Virji". London. 2017-05-08
Fluidigm Corporation. (5/4/17). "Press Release: European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research". South San Francisco, CA. 2017-05-04
Cambridge Enterprise. (5/3/17). "Press Release: Spin-out Z Factor Announces £7 million Series A Funding to Bring Lung Treatment to the Clinic". 2017-05-03
MiNA Therapeutics Ltd.. (5/3/17). "Press Release: Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics". Tokyo & London. 2017-05-03
GammaDelta Therapeutics Ltd.. (5/3/17). "Press Release: GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO". London. 2017-05-03
Adaptimmune Therapeutics plc. (5/2/17). "Press Release: Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference". Philadeliphia, PA & Oxford. 2017-05-02
Metrion Biosciences Ltd.. (5/2/17). "Press Release: Metrion Biosciences Appoints Chief Operating Officer and Head of Business Development". Cambridge. 2017-05-02
Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London. 2017-04-27
Congenica Ltd.. (4/27/17). "Press Release: Congenica Completes Series B Financing Round with Investments from China-based BGI, Healthlink and Future Planet". Cambridge. 2017-04-27
Microsaic Systems plc. (4/26/17). "Press Release: Integration with SCPA Chromatography Software". 2017-04-26
Metrion Biosciences Ltd.. (4/24/17). "Press Release: Metrion Biosciences and Venomtech Announce Research Collaboration". Cambridge. 2017-04-24
Bicycle Therapeutics Ltd.. (4/20/17). "Press Release: Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with Thrombogenics". Cambridge, MA & Cambridge. 2017-04-20
OBN (UK) Ltd.. (4/20/17). "Press Release: OBN Appoints New Director to Enhance Board Expertise". Abingdon. 2017-04-20
Redx Pharma plc. (4/20/17). "Press Release: Appointment of Chairman". 2017-04-20
Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford. 2017-04-19
Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje. 2017-04-18
CRISPR Therapeutics AG. (4/17/17). "Press Release: CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio". Basel, et al.. 2017-04-17
HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. 2017-04-12
Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. 2017-04-12
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. 2017-04-11
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD. 2017-04-10
Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. 2017-04-10
Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. 2017-04-10
Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". 2017-04-07
Pirbright Institute, The. (4/7/17). "Press Release: Dr. Bryan Charleston Appointed as Director of The Pirbright Institute". 2017-04-07
MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. 2017-04-06
Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-04-05
Heptares Therapeutics Ltd.. (4/5/17). "Press Release: Heptares to Receive US$12 Million Milestone Payment from AstraZeneca". London. 2017-04-05
SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester. 2017-04-05
Nightstar Therapeutics plc. (4/4/17). "Press Release: NightstaRx Appoints Healthcare Finance Leader Senthil Sundaram as Chief Financial Officer". Boston, MA. 2017-04-04
LGC Ltd.. (4/3/17). "Press Release: LGC Acquires Axolabs and Invests in GMP Manufacturing Capacity for Therapeutic Nucleic Acids". 2017-04-03
Bicycle Therapeutics Ltd.. (4/3/17). "Press Release: Bicycle Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting". Cambridge, MA & Cambridge. 2017-04-03
AstraZeneca plc. (3/31/17). "Press Release: Tagrisso (osimertinib) Receives US FDA Full Approval". 2017-03-31
Oxford BioMedica plc. (3/30/17). "Press Release: Oxford BioMedica Notes Acceptance by FDA of a Biologics License Application (BLA) Filing for CTL019". Oxford. 2017-03-30
Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. 2017-03-30
Redx Pharma plc. (3/30/17). "Press Release: Redx Pharma Awarded US$1 Million Grant by CARB-X". 2017-03-30
Linguamatics Ltd.. (3/28/17). "Press Relase: Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research". Cambridge & Boston, MA. 2017-03-28
Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin. 2017-03-27
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-27
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford. 2017-03-27
Cancer Research UK. (3/24/17). "Press Release: New Era in Precision Medicine for Pancreatic Cancer". 2017-03-24
Unit DX. (3/23/17). "Press Release: Our Opening Event. The future looks bright for Science in Bristol". 2017-03-23
Regeneron Pharmaceuticals, Inc.. (3/22/17). "Press Release: U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis". Tarrytown, NY. 2017-03-22
Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-22
Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". 2017-03-21
Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-21
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". 2017-03-21
Thermo Fisher Scientific Inc.. (3/21/17). "Press Release: Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain". London. 2017-03-21
Redx Pharma plc. (3/21/17). "Press Release: Final Results for the Year Ended 30 September 2016". 2017-03-21
Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London. 2017-03-20
Eurofins Scientific UK. (3/17/17). "Press Release: Eurofins to Invest Millions in New UK Facility". 2017-03-17
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease". 2017-03-17
Cell Medica Ltd.. (3/16/17). "Press Release: £60 Million Series C Financing to Advance Multiple Cancer Programmes". London. 2017-03-16
Adaptimmune Therapeutics plc. (3/15/17). "Press Release: Adaptimmune Broadens Executive Team". Philadeliphia, PA & Oxford. 2017-03-15
AstraZeneca plc. (3/14/17). "Press Release: Lynparza Phase III SOLO-2 Data Demonstrate Progression-free Survival Benefit in BRCA-mutated Ovarian Cancer as Maintenance Therapy". 2017-03-14
Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. 2017-03-13
Heptares Therapeutics Ltd.. (3/13/17). "Press Release: Heptares Enters Agreement with Daiichi Sankyo to Discover and Develop Novel, Small Molecules for the Treatment of Pain". London. 2017-03-13
Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. 2017-03-13
University of Sheffield. (3/7/17). "Press Release: Keapstone Therapeutics Launched in World-first Partnership to Develop New Drugs for Parkinson’s". 2017-03-07
GlaxoSmithKline plc. (3/6/17). "Press Release: GSK’s MUSCA Study Shows Nucala (mepolizumab) Significantly Improves Quality of Life and Lung Function in Severe Asthma Patients with an Eosinophilic Phenotype". London. 2017-03-06
Prothena Corporation plc. (3/3/17). "Press Release: Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares". Dublin. 2017-03-03
Prothena Corporation plc. (3/2/17). "Press Release: Prothena Announces Public Offering of Ordinary Shares". Dublin. 2017-03-02
Merck KGaA. (3/2/17). "Press Release: NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC". Darmstadt. 2017-03-02
Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. 2017-03-02
PureTech Health plc. (3/2/17). "Press Release: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy". Boston, MA. 2017-03-02
Bicycle Therapeutics Ltd.. (3/2/17). "Press Release: Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference". Cambridge, MA & Cambridge. 2017-03-02
Arquer Diagnostics Ltd.. (3/1/17). "Press Release: Arquer Diagnostics Awarded Funding Under Innovate UK’s Biocatalyst Programme". Sunderland. 2017-03-01
GlaxoSmithKline plc. (3/1/17). "Press Release: GSK Confirms Closure of Agreement to Divest Anaesthesia Portfolio to Aspen". London. 2017-03-01
AstraZeneca plc. (2/28/17). "Press Release: FDA Approves Once-daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes". 2017-02-28
Oxford BioMedica plc. (2/28/17). "Press Release: Appointment of New Chief Financial Officer". Oxford. 2017-02-28
Oryzon Genomics S.A.. (2/27/17). "Press Release: Oryzon Presented New Preclinical Data of ORY-2001 Therapeutic Activity in Multiple Sclerosis at ACTRIMS-2017". Barcelona & Cambridge, MA. 2017-02-27
Congenica Ltd.. (2/27/17). "Press Release: Congenica Raises £8M ($10M) in Series B Financing Round to Drive International Expansion of Its Genome Analysis Business". Cambridge. 2017-02-27
Premaitha Health plc. (2/27/17). "Press Release: Completion of Yourgene Acquisition, Issue of Shares and Director Appointments". Manchester. 2017-02-27
AstraZeneca plc. (2/24/17). "Press Release: ZS-9 (sodium zirconium cyclosilicate) Receives Positive CHMP Opinion for the Treatment of Hyperkalaemia". 2017-02-24
Napp Pharmaceuticals Ltd.. (2/24/17). "Press Release: Napp Launches Truxima (rituximab), the First Biosimilar Monoclonal Antibody for the Treatment of Cancer, in the UK". Cambridge. 2017-02-24
PureTech Health plc. (2/24/17). "Press Release: PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference". Boston, MA. 2017-02-24
Storm Therapeutics Ltd.. (2/24/17). "Press Release: Storm Therapeutics Appoints CEO and Chairman". 2017-02-24
GlaxoSmithKline plc. (2/23/17). "Press Release: Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-controlled Asthma". London. 2017-02-23
Horizon Discovery Group plc. (2/23/17). "Press Release: Site Visit. Location – Cambridge". Cambridge. 2017-02-23
Apollo Therapeutics Fund. (2/22/17). "Press Release: Apollo Therapeutics – Funding of Four Initial Projects and Operational Update". Stevenage. 2017-02-22
Evotec AG. (2/21/17). "Press Release: »Lab282« Awarded First Projects. Oxford University and Evotec's Drug Discovery Partnership Launched Last November to Accelerate Drugs to Market Begins Making Awards". Hamburg. 2017-02-21
MorphoSys AG. (2/21/17). "Press Release: MorphoSys’s Subsidiary Lanthio Pharma Initiates First-in-Human Clinical Study with Lanthipeptide MOR107". Planegg. 2017-02-21
Genedata AG. (2/21/17). "Press Release: Genedata Expands into United Kingdom". Basel. 2017-02-21
Horizon Discovery Group plc. (2/20/17). "Press Release: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma". Cambridge. 2017-02-20
AstraZeneca plc. (2/20/17). "Press Release: AstraZeneca Enters Agreement with TerSera Therapeutics for Zoladex in the US and Canada". 2017-02-20
Centauri Therapeutics Ltd.. (2/20/17). "Press Release: Centauri Therapeutics Ltd Closes £2.5m Fundraising". London & Kent. 2017-02-20
Consilium Strategic Communications Ltd.. (2/20/17). "Press Release: Consilium Strategic Communications Advises Arix Bioscience plc on Its Successful £100 Million Fundraise and IPO on the Main Market of the London Stock Exchange". London. 2017-02-20
University of Warwick. (2/17/17). "Press Release: Molecular Phenomenon Discovered by Advanced NMR Facility". 2017-02-17
Almac Group Ltd.. (2/16/17). "Press Release: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations". Craigavon. 2017-02-16
Luxcel Biosciences Ltd.. (2/15/17). "Press Release: Luxcel Biosciences Ltd, Axiogenesis AG and BMG LABTECH GmbH Secure €2.5m European Investment to Develop and Launch Cell Metabolism Analysis Platform: »MetaCell-TM«". Cork. 2017-02-15
Quotient Clinical. (2/14/17). "Press Release: Quotient Clinical Announces Second US Acquisition – QS Pharma". Nottingham. 2017-02-14
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top